{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:27:30Z","timestamp":1790692050018,"version":"4.1.0"},"reference-count":81,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Marijuana, also known as cannabis, is the second most widely used illegal\npsychoactive substance smoked worldwide after tobacco, mainly due to the psychoactive effects\ninduced by D-9-tetrahydrocannabinol (9-THC). Cannabidiol (CBD) is extracted from cannabis\nand may be used as an anti-inflammatory agent. Some patents on cannabidiol are discussed in\nthis review. The cannabinoid is a non-psychoactive isomer of the more infamous tetrahydrocannabinol\n(THC); and is available in several administration modes, most known as CBD oil.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This study aims to provide an enhanced review of cannabidiol properties used in treating\ninflammation. This review also emphasises the current safety profile of cannabidiol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>Cannabis is also called Marijuana. It is the second most commonly used illegal psychoactive\nsubstance in the universe after tobacco. D-9-tetrahydrocannabinol (9-THC) present in cannabis\nproduces psychoactive effects. Cannabidiol (CBD) extracted from cannabis is used for antiinflammatory\npurposes. Cannabis smoking causes various types of cancer, such as lung, tongue,\nand jaw. The current review took literature from Google Scholar, PubMed, and Google Patents.\nMany clinical investigations are included in this review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result:<\/jats:title>\n                    <jats:p>After analysing the literature on cannabis, it has been suggested that although cannabis is\nbanned in some countries, it may be included in the treatment and mitigation of some diseases and\nsymptoms like pain management, epilepsy, cancer, and anxiety disorder. Mild side effects were\nfrequently observed in cannabis medications, which included infertility in females, liver damage,\netc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Cannabis contains chemical compounds such as the cannabinoids delta-9-\ntetrahydrocannabinol (THC), a psychoactive substance, and non-psychoactive cannabidiol (CBD).\nCannabidiol has been confirmed as an efficient treatment of epilepsy in several clinical trials, with\none pure CBD product named Epidiolex. It is also used in treating anxiety and acne, as a pain reliever,\nand has anti-inflammatory properties.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1574886317666220902100511","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T08:45:26Z","timestamp":1662194726000},"page":"465-473","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Current Cannabidiol Safety: A Review"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7346-4920","authenticated-orcid":true,"given":"Chander","family":"Singh","sequence":"additional","affiliation":[{"name":"School of Medical &amp; Allied Sciences, K. R. Mangalam University, Sohna Road, Gurugram- 122103, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-7465","authenticated-orcid":true,"given":"Komal","family":"Rao","sequence":"additional","affiliation":[{"name":"School of Medical &amp; Allied Sciences, K. R. Mangalam University, Sohna Road, Gurugram- 122103, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2863-071X","authenticated-orcid":true,"given":"Nikita","family":"Yadav","sequence":"additional","affiliation":[{"name":"School of Medical &amp; Allied Sciences, K. R. Mangalam University, Sohna Road, Gurugram- 122103, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-4060","authenticated-orcid":true,"given":"Yogesh","family":"Vashist","sequence":"additional","affiliation":[{"name":"School of Medical &amp; Allied Sciences, K. R. Mangalam University, Sohna Road, Gurugram- 122103, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8221-7283","authenticated-orcid":true,"given":"Palak","family":"Chugh","sequence":"additional","affiliation":[{"name":"School of Medical &amp; Allied Sciences, K. R. Mangalam University, Sohna Road, Gurugram- 122103, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3788-6568","authenticated-orcid":true,"given":"Nidhi","family":"Bansal","sequence":"additional","affiliation":[{"name":"School of Medical &amp; Allied Sciences, K. R. Mangalam University, Sohna Road, Gurugram- 122103, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0870-4972","authenticated-orcid":true,"given":"Neha","family":"Minocha","sequence":"additional","affiliation":[{"name":"School of Medical &amp; Allied Sciences, K. R. Mangalam University, Sohna Road, Gurugram- 122103, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.22541\/au.159318524.43742889","author":"Omare M.","year":"2020","unstructured":"Omare M.; Kibet J.; Cherutoi J.; Kengara F.; A review of the current trends on the use of Cannabis sativa for recreational, medicinal applications, and its toxicological health impacts. Authorea 2020","journal-title":"Authorea"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3389\/fphar.2019.01481","volume":"10","author":"Archie S.R.","year":"2019","unstructured":"Archie S.R.; Cucullo L.; Harmful effects of smoking cannabis: a cerebrovascular and neurological perspective. Front Pharmacol 2019,10,1481","journal-title":"Front Pharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1007\/s00213-019-05283-3","volume":"236","author":"Borgan F.","year":"2019","unstructured":"Borgan F.; Beck K.; Butler E.; The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species. Psychopharmacology 2019,236(11),3257-3270","journal-title":"Psychopharmacology"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.160105897","author":"Malfait A.M.","year":"2000","unstructured":"Malfait A.M.; Gallily R.; Sumariwalla P.F.;  The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis 2000","journal-title":"The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis"},{"key":"ref=5","year":"2018","unstructured":"WHO Expert committee on drug dependence: fortieth report. WHOAvailable from: 2018"},{"key":"ref=6","first-page":"e341","volume":"3","year":"2018","unstructured":"All studies reported ADE N. Symptoms of Cannabis Withdrawal. Lancet 2018,3,e341-e350","journal-title":"Lancet"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3109\/15563650.2015.1100306","volume":"53","author":"Tyndall J.A.","year":"2015","unstructured":"Tyndall J.A.; Gerona R.; De Portu G.; An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA. Clin Toxicol 2015,53(10),950-956","journal-title":"Clin Toxicol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/pr9060936","volume":"9","author":"Kim N.P.","year":"2021","unstructured":"Kim N.P.; Aditya A.; Kang H.J.; Park H.D.; Unique approach of a telemedicine system for CBD-infused foods. Processes 2021,9(6),936","journal-title":"Processes"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1373\/clinchem.2016.263475","volume":"62","author":"Newmeyer M.N.","year":"2016","unstructured":"Newmeyer M.N.; Swortwood M.J.; Barnes A.J.; Abulseoud O.A.; Scheidweiler K.B.; Huestis M.A.; Free and glucuronide whole blood cannabinoids\u2019 pharmacokinetics after controlled smoked, vaporized, and oral cannabis administration in frequent and occasional cannabis users: identification of recent cannabis intake. Clin Chem 2016,62(12),1579-1592","journal-title":"Clin Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/2050-6511-15-58","volume":"15","author":"Solowij N.","year":"2014","unstructured":"Solowij N.; Broyd S.J.; van Hell H.H.; Hazekamp A.; A protocol for the delivery of cannabidiol (CBD) and combined CBD and \u22069-tetrahydrocannabinol (THC) by vaporisation. BMC Pharmacol Toxicol 2014,15(1),58","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jclinane.2019.03.011","volume":"57","author":"Echeverria V.M.","year":"2019","unstructured":"Echeverria V.M.; Todeschini A.B.; Stoicea N.; Fiorda D.J.; Weaver T.; Bergese S.D.; Perioperative care of cannabis users: A comprehensive review of pharmacological and anesthetic considerations. J Clin Anesth 2019,57,41-49","journal-title":"J Clin Anesth"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/bmc.1130030109","volume":"3","author":"Johansson E.","year":"1989","unstructured":"Johansson E.; Nor&#xE9;n K.; Sj&#xF6;vall J.; Halldin M.M.; Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry. Biomed Chromatogr 1989,3(1),35-38","journal-title":"Biomed Chromatogr"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/bcp.13710","volume":"84","author":"Lucas C.J.","year":"2018","unstructured":"Lucas C.J.; Galettis P.; Schneider J.; The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol 2018,84(11),2477-2482","journal-title":"Br J Clin Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"Grotenhermen F.","year":"2003","unstructured":"Grotenhermen F.; Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003,42(4),327-360","journal-title":"Clin Pharmacokinet"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/bms.1200130206","volume":"13","author":"Ohlsson A.","year":"1986","unstructured":"Ohlsson A.; Lindgren J.E.; Andersson S.; Agurell S.; Gillespie H.; Hollister L.E.; Single-dose kinetics of deuterium labelled cannabidiol in man after smoking and intravenous administration. Biomed Environ Mass Spectrom 1986,13(2),77-83","journal-title":"Biomed Environ Mass Spectrom"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"Huestis M.A.","year":"2007","unstructured":"Huestis M.A.; Human cannabinoid pharmacokinetics. Chem Biodivers 2007,4(8),1770-1804","journal-title":"Chem Biodivers"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s40262-017-0599-0","volume":"57","author":"Martin J.H.","year":"2018","unstructured":"Martin J.H.; Schneider J.; Lucas C.J.; Galettis P.; Exogenous cannabinoid efficacy: merely a pharmacokinetic interaction? Clin Pharmacokinet 2018,57(5),539-545","journal-title":"Clin Pharmacokinet"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/jat\/32.7.470","volume":"32","author":"Toennes S.W.","year":"2008","unstructured":"Toennes S.W.; Ramaekers J.G.; Theunissen E.L.; Moeller M.R.; Kauert G.F.; Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint. J Anal Toxicol 2008,32(7),470-477","journal-title":"J Anal Toxicol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.soncn.2019.04.012","volume":"35","author":"Byars T.","year":"2019","unstructured":"Byars T.; Theisen E.; Bolton D.L.; Using cannabis to treat cancer related pain. Seminars in Oncology Nursing In: Elsevier Amsterdam 2019,35(3),300-309","journal-title":"Seminars in Oncology Nursing In: Elsevier Amsterdam"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.yebeh.2016.11.016","volume":"70","author":"Gaston T.E.","year":"2017","unstructured":"Gaston T.E.; Friedman D.; Pharmacology of cannabinoids in the treatment of epilepsy. Epilepsy Behav 2017,70,313-318","journal-title":"Epilepsy Behav"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/BF02085029","volume":"37","author":"Agurell S.","year":"1981","unstructured":"Agurell S.; Carlsson S.; Lindgren J.E.; Ohlsson A.; Gillespie H.; Hollister L.; Interactions of\u0394 11-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography. Experientia 1981,37(10),1090-1092","journal-title":"Experientia"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1055\/s-0031-1298334","volume":"78","author":"Eichler M.","year":"2012","unstructured":"Eichler M.; Spinedi L.; Unfer G.S.; Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects. Planta Med 2012,78(7),686-691","journal-title":"Planta Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/03602532.2015.1137307","volume":"48","author":"Dinis R.J.","year":"2016","unstructured":"Dinis R.J.; Metabolomics of \u03949-tetrahydrocannabinol: Implications in toxicity. Drug Metab Rev 2016,48(1),80-87","journal-title":"Drug Metab Rev"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/3-540-26573-2_23","author":"Huestis M.A.","year":"2005","unstructured":"Huestis M.A.;  Pharmacokinetics and metabolism of the plant cannabinoids, \u0394 9-tetrahydrocannibinol, cannabidiol and cannabinol 2005,657-690","journal-title":"Pharmacokinetics and metabolism of the plant cannabinoids, \u0394 9-tetrahydrocannibinol, cannabidiol and cannabinol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0378-5173(02)00262-4","volume":"241","author":"Challapalli P.V.","year":"2002","unstructured":"Challapalli P.V.; Stinchcomb A.L.; In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation. Int J Pharm 2002,241(2),329-339","journal-title":"Int J Pharm"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jconrel.2003.09.001","volume":"93","author":"Lodzki M.","year":"2003","unstructured":"Lodzki M.; Godin B.; Rakou L.; Mechoulam R.; Gallily R.; Touitou E.; Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. J Control Release 2003,93(3),377-387","journal-title":"J Control Release"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1211\/0022357022791","volume":"56","author":"Stinchcomb A.L.","year":"2004","unstructured":"Stinchcomb A.L.; Valiveti S.; Hammell D.C.; Ramsey D.R.; Human skin permeation of \u03948-tetrahydrocannabinol, cannabidiol and cannabinol. J Pharm Pharmacol 2004,56(3),291-297","journal-title":"J Pharm Pharmacol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.yebeh.2016.11.006","volume":"70","author":"Rosenberg EC","year":"2017","unstructured":"Rosenberg EC; Patra PH; Whalley BJ; Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy related neuroprotection. Epilepsy Behav 2017,70(Pt B),319-327","journal-title":"Epilepsy Behav"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2174\/1570159X15666161111114214","volume":"15","author":"Schaefer N.","year":"2017","unstructured":"Schaefer N.; Kettner M.; Laschke M.W.; Distribution of synthetic cannabinoids JWH-210, RCS-4 and \u0394 9-Tetrahydrocannabinol after intravenous administration to pigs. Curr Neuropharmacol 2017,15(5),713-723","journal-title":"Curr Neuropharmacol"},{"key":"ref=30","first-page":"35","volume":"215","author":"Hunt C.A.","year":"1980","unstructured":"Hunt C.A.; Jones R.T.; Tolerance and disposition of tetrahydrocannabinol in man. J Pharmacol Exp Ther 1980,215(1),35-44","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.clinthera.2017.12.008","volume":"40","author":"Lucas C.J.","year":"2018","unstructured":"Lucas C.J.; Galettis P.; Song S.; Cannabinoid disposition after human intraperitoneal use: An insight into intraperitoneal pharmacokinetic properties in metastatic cancer. Clin Ther 2018,40(9),1442-1447","journal-title":"Clin Ther"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1389200217666151210142051","volume":"17","author":"Zendulka O.","year":"2016","unstructured":"Zendulka O.; Dovrt&#x11B;lov&#xE1; G.; Noskov&#xE1; K.; Cannabinoids and cytochrome P450 interactions. Curr Drug Metab 2016,17(3),206-226","journal-title":"Curr Drug Metab"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1373\/clinchem.2011.171777","volume":"57","author":"Schwope D.M.","year":"2011","unstructured":"Schwope D.M.; Karschner E.L.; Gorelick D.A.; Huestis M.A.; Identification of recent cannabis use: Whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clin Chem 2011,57(10),1406-1414","journal-title":"Clin Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.177.4043.62","volume":"177","author":"Lemberger L.","year":"1972","unstructured":"Lemberger L.; Crabtree R.E.; Rowe H.M.; 11-hydroxy- 9 -tetrahydrocannabinol: Pharmacology, disposition, and metabolism of a major metabolite of marihuana in man. Science 1972,177(4043),62-64","journal-title":"Science"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJM198209233071311","volume":"307","author":"Perez R.M.","year":"1982","unstructured":"Perez R.M.; Wall M.E.; Presence of delta9-tetrahydrocannabinol in human milk. N Engl J Med 1982,307(13),819-820","journal-title":"N Engl J Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","volume":"40","author":"Consroe P.","year":"1991","unstructured":"Consroe P.; Laguna J.; Allender J.; Controlled clinical trial of cannabidiol in Huntington\u2019s disease. Pharmacol Biochem Behav 1991,40(3),701-708","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40262-014-0195-5","volume":"54","author":"Heuberger J.A.","year":"2015","unstructured":"Heuberger J.A.; Guan Z.; Oyetayo O.O.; Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short and long term pharmacokinetics. Clin Pharmacokinet 2015,54(2),209-219","journal-title":"Clin Pharmacokinet"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2174\/1871527316666170413104516","volume":"16","author":"Arellano A.L.","year":"2017","unstructured":"Arellano A.L.; Papaseit E.; Romaguera A.; Torrens M.; Farr&#xE9; M.; Neuropsychiatric and general interactions of natural and synthetic cannabinoids with drugs of abuse and medicines. CNS and Neurol Disord Drug Targets 2017,16(5),554-566","journal-title":"CNS and Neurol Disord Drug Targets"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0376-8716(01)00118-1","volume":"64","author":"Lukas S.E.","year":"2001","unstructured":"Lukas S.E.; Orozco S.; Ethanol increases plasma \u0394(9)-tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteers. Drug Alcohol Depend 2001,64(2),143-149","journal-title":"Drug Alcohol Depend"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1600-0447.1989.tb10296.x","volume":"79","author":"Andr&#xE9;asson S.","year":"1989","unstructured":"Andr&#xE9;asson S.; Allebeck P.; Rydberg U.; Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand 1989,79(5),505-510","journal-title":"Acta Psychiatr Scand"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S2215-0366(15)00363-6","volume":"3","author":"Schoeler T.","year":"2016","unstructured":"Schoeler T.; Monk A.; Sami M.B.; Continued versus discontinued cannabis use in patients with psychosis: A systematic review and meta-analysis. Lancet Psychiatry 2016,3(3),215-225","journal-title":"Lancet Psychiatry"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.amjcard.2013.09.042","volume":"113","author":"Thomas G.","year":"2014","unstructured":"Thomas G.; Kloner R.A.; Rezkalla S.; Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol 2014,113(1),187-190","journal-title":"Am J Cardiol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","volume":"29","author":"D\u2019Souza D.C.","year":"2004","unstructured":"D\u2019Souza D.C.; Perry E.; MacDougall L.; The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology 2004,29(8),1558-1572","journal-title":"Neuropsychopharmacology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/clpt.2010.318","volume":"89","author":"Karschner E.L.","year":"2011","unstructured":"Karschner E.L.; Darwin W.D.; McMahon R.P.; Subjective and physiological effects after controlled Sativex and oral THC administration. Clin Pharmacol Ther 2011,89(3),400-407","journal-title":"Clin Pharmacol Ther"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/clpt.2009.62","volume":"86","author":"Dumont G.J.","year":"2009","unstructured":"Dumont G.J.; Kramers C.; Sweep F.C.; Cannabis coadministration potentiates the effects of &#x201C;ecstasy&#x201D; on heart rate and temperature in humans. Clin Pharmacol Ther 2009,86(2),160-166","journal-title":"Clin Pharmacol Ther"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/cpt1977213336","volume":"21","author":"Benowitz N.L.","year":"1977","unstructured":"Benowitz N.L.; Jones R.T.; Prolonged delta-9-tetrahydrocannabinol ingestion. Effects of sympathomimetic amines and autonomic blockades. Clin Pharmacol Ther 1977,21(3),336-342","journal-title":"Clin Pharmacol Ther"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0091-3057(87)90506-5","volume":"28","author":"Foltin R.W.","year":"1987","unstructured":"Foltin R.W.; Fischman M.W.; Pedroso J.J.; Pearlson G.D.; Marijuana and cocaine interactions in humans: Cardiovascular consequences. Pharmacol Biochem Behav 1987,28(4),459-464","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","volume":"66","author":"Russo E.","year":"2006","unstructured":"Russo E.; Guy G.W.; A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses 2006,66(2),234-246","journal-title":"Med Hypotheses"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1017\/S0033291715001178","volume":"45","author":"Freeman T.P.","year":"2015","unstructured":"Freeman T.P.; Winstock A.R.; Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychol Med 2015,45(15),3181-3189","journal-title":"Psychol Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.11.004","volume":"115","author":"Lopez Q.C.","year":"2011","unstructured":"Lopez Q.C.; P&#xE9;rez de los Cobos J.; Hasin D.S.; Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey On Alcohol And Related Conditions (NESARC). Drug Alcohol Depend 2011,115(1-2),120-130","journal-title":"Drug Alcohol Depend"},{"key":"ref=51","author":"John J.","year":"2020","unstructured":"John J.; Everything you need to know about CBD oil. Medical News Today. Available from: 2020"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2018.02.016","volume":"329","author":"Li H.","year":"2018","unstructured":"Li H.; Kong W.; Chambers C.R.; The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice. Cell Immunol 2018,329,1-9","journal-title":"Cell Immunol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","volume":"38","author":"Morgan C.J.","year":"2013","unstructured":"Morgan C.J.; Das R.K.; Joye A.; Curran H.V.; Kamboj S.K.; Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings. Addict Behav 2013,38(9),2433-2436","journal-title":"Addict Behav"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/add.14243","volume":"113","author":"Hindocha C.","year":"2018","unstructured":"Hindocha C.; Freeman T.P.; Grabski M.; Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal. Addiction 2018,113(9),1696-1705","journal-title":"Addiction"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s13311-015-0373-7","volume":"12","author":"Hurd Y.L.","year":"2015","unstructured":"Hurd Y.L.; Yoon M.; Manini A.F.; Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage. Neurotherapeutics 2015,12(4),807-815","journal-title":"Neurotherapeutics"},{"key":"ref=56","year":"2020","unstructured":"FDA Approves New Indication for Drug containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease. Available from: 2020"},{"key":"ref=57","unstructured":"Epidiolex. Medical News Today. Available from:"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pbb.2019.05.002","volume":"181","author":"Zieba J.","year":"2019","unstructured":"Zieba J.; Sinclair D.; Sebree T.; Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism. Pharmacol Biochem Behav 2019,181,93-100","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","volume":"12","author":"Blessing E.M.","year":"2015","unstructured":"Blessing E.M.; Steenkamp M.M.; Manzanares J.; Marmar C.R.; Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics 2015,12(4),825-836","journal-title":"Neurotherapeutics"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1172\/JCI64628","volume":"124","author":"Ol&#xE1;h A.","year":"2014","unstructured":"Ol&#xE1;h A.; T&#xF3;th B.I.; Borb&#xED;r&#xF3; I.; Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. J Clin Invest 2014,124(9),3713-3724","journal-title":"J Clin Invest"},{"key":"ref=61","year":"2020","unstructured":"FDA Regulations of Cannabis and Cannabis Derived Products, Including Cannabidiol (CBD). Retrieved from: .2020"},{"key":"ref=62","first-page":"12","volume":"15","author":"Naik S.","year":"2018","unstructured":"Naik S.; Kolikonda M.; Prabhu A.; Lippmann S.; Marijuana on the brain- A concern. Innov Clin Neurosci 2018,15(1-2),12","journal-title":"Innov Clin Neurosci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-1-4684-0823-2_3","author":"Hoffmann D.B.","year":"1975","unstructured":"Hoffmann D.B.; Brunnemann K.D.; Gori G.B.; Wynder E.L.; On the carcinogenicity of marijuana smoke. In: Recent Advances in Phytochemistry 1975,63-81","journal-title":"Recent Advances in Phytochemistry"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJM198802113180603","volume":"318","author":"Wu T.C.","year":"1988","unstructured":"Wu T.C.; Tashkin D.P.; Djahed B.; Rose J.E.; Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 1988,318(6),347-351","journal-title":"N Engl J Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1021\/tx700275p","volume":"21","author":"Moir D.","year":"2008","unstructured":"Moir D.; Rickert W.S.; Levasseur G.; A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol 2008,21(2),494-502","journal-title":"Chem Res Toxicol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/0091-3057(91)90378-F","volume":"40","author":"Tashkin D.P.","year":"1991","unstructured":"Tashkin D.P.; Gliederer F.; Rose J.; Tar, CO and delta 9THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharmacol Biochem Behav 1991,40(3),657-661","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/rccm.2043P5","volume":"204","author":"Heinicke G.","year":"2021","unstructured":"Heinicke G.; Clay R.; DeCato T.W.; Six minute walk testing. ATS patient education series. American Thoracic Society. Am J Respir Crit Care Med 2021,204,9-10","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e1916318","DOI":"10.1001\/jamanetworkopen.2019.16318","volume":"2","author":"Ghasemiesfe M.","year":"2019","unstructured":"Ghasemiesfe M.; Barrow B.; Leonard S.; Keyhani S.; Korenstein D.; Association between marijuana use and risk of cancer: A systematic review and meta-analysis. JAMA Netw Open 2019,2(11),e1916318","journal-title":"JAMA Netw Open"},{"key":"ref=69","volume":"11","author":"Shakya G.","year":"2015","unstructured":"Shakya G.; Balasubramanian S.; Rajagopalan R.; Methanol extract of wheatgrass induces G1 cell cycle arrest in a p53-dependent manner and down regulates the expression of cyclin D1 in human laryngeal cancer cells-an in vitro and in silico approach. Pharmacognosy Magazine 2015,11(42)","journal-title":"Pharmacognosy Magazine"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.otohns.2007.12.002","volume":"138","author":"Sarah B.M.B.S.","year":"2008","unstructured":"Sarah B.M.B.S.; Matire H.; Brian C.; Cannabis use and cancer of the head and neck: Case control study. Otolaryngol Head Neck Surg 2008,138,374-380","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref=71","first-page":"098","volume":"5","author":"Singh H","year":"2019","unstructured":"Singh H; Katz J; Saleh W; Cha S; Impact of cannabis on the port of entry-oral tissues: An overview. Int J Oral Dent Health 2019,5,098","journal-title":"Int J Oral Dent Health"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1601-5037.2008.00301.x","volume":"6","author":"Versteeg P.A.","year":"2008","unstructured":"Versteeg P.A.; Slot D.E.; van der Velden U.; van der Weijden G.A.; Effect of cannabis usage on the oral environment: A review. Int J Dent Hyg 2008,6(4),315-320","journal-title":"Int J Dent Hyg"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1600-0528.1993.tb00725.x","volume":"21","author":"Darling M.R.","year":"1993","unstructured":"Darling M.R.; Arendorf T.M.; Effects of cannabis smoking on oral soft tissues. Community Dent Oral Epidemiol 1993,21(2),78-81","journal-title":"Community Dent Oral Epidemiol"},{"key":"ref=74","first-page":"576","volume":"119","author":"Schulz K.M.","year":"2009","unstructured":"Schulz K.M.; Imfeld T.; Imfeld C.; Cannabis and caries-does regular cannabis use increase the risk of caries in cigarette smokers? Schweiz Monatsschr Zahnmed 2009,119(6),576-583","journal-title":"Schweiz Monatsschr Zahnmed"},{"key":"ref=75","first-page":"631","volume":"97","author":"Pikkarainen P.H.","year":"1981","unstructured":"Pikkarainen P.H.; Baraona E.; Jauhonen P.; Seitz H.K.; Lieber C.S.; Contribution of oropharynx microflora and of lung microsomes to acetaldehyde in expired air after alcohol ingestion. J Lab Clin Med 1981,97(5),631-636","journal-title":"J Lab Clin Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0003-9969(81)90031-5","volume":"26","author":"Di Cugno F.","year":"1981","unstructured":"Di Cugno F.; Perec C.J.; Tocci A.A.; Salivary secretion and dental caries experience in drug addicts. Arch Oral Biol 1981,26(5),363-367","journal-title":"Arch Oral Biol"},{"key":"ref=77","author":"Berl V","year":"2019","unstructured":"Berl V; Xiac. New Age Nanotech LLC, Stabilized formulations ofcannabinoid compositions. 2019"},{"key":"ref=78","author":"Bradley MB","year":"2015","unstructured":"Bradley MB; Cannabidiol (CBD) enriched alcohol. 2015"},{"key":"ref=79","author":"Def LLC","year":"2016","unstructured":"Def LLC; Topical regional neuro-affective therapy with cannabinoids. 2016"},{"key":"ref=80","author":"Michael JM","year":"2015","unstructured":"Michael JM; Joshua A, H; Greg W; Process for generating hemp oil with a high cannabidiol (CBD) content. 2015"},{"key":"ref=81","author":"Heller M.","year":"2018","unstructured":"Heller M.; Methodology and formulation for creating a powder of an encapsulated cannabis-based component embedded in a polymer matrix. 2018"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886317666220902100511","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208446\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886317666220902100511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T08:09:19Z","timestamp":1691309359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208446\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886317666220902100511","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}